Inactive Instrument

Press Releases Neovasc Inc.

Equities

Neovasc : Notice of Change in Corporate Structure - Form 6-K	23-04-12	PU
Neovasc Announces Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Corporate Update	23-04-03	AQ
Neovasc: Q4 Earnings Snapshot	23-03-31	AQ
Neovasc Announces Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Corporate Update	23-03-31	GL
Neovasc : Shareholders Approve Acquisition by Shockwave Medical	23-03-06	PU
Neovasc Announces German Reimbursement Renewal	23-02-01	AQ
Neovasc : Notice of the Meeting and Record Date - Form 6-K	23-01-27	PU
IIROC Trade Resumption - NVCN	23-01-17	AQ
IIROC Trading Halt - NVCN	23-01-17	AQ
Shockwave Medical Announces Agreement to Acquire Neovasc	23-01-17	AQ
Shockwave Medical to Acquire Neovasc	23-01-17	AQ
Neovasc Announces Progress on COSIRA-II Clinical Trial	22-11-28	AQ
Neovasc Comments on European Heart Journal Publication	22-11-18	AQ
Neovasc: Q3 Earnings Snapshot	22-11-10	AQ
Neovasc Announces Third Quarter Financial Results and Provides Corporate Update	22-11-10	AQ
Neovasc Reducer Obtains U.S. Outpatient Reimbursement	22-11-08	AQ
Neovasc to Report Third Quarter Financial Results on November 10, 2022	22-10-27	AQ
Neovasc : New Data Presented on the Neovasc Reducer™ in Patients With Microvascular Disease - Form 6-K	22-09-20	PU
Neovasc Provides Corporate Update Following Clinical Data Release	22-09-20	AQ
Neovasc to Participate in LSI Europe 2022 Emerging MedTech Summit	22-09-16	AQ

No results for this search